Loading...
Loading...

Nephrocare Health Services Ltd., incorporated in 2010, provides comprehensive dialysis care through a network of clinics in India and select international markets. The company offers various services, including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of September 30, 2025, Nephrocare operated 519 clinics, including the world's largest dialysis clinic in Uzbekistan, and served 29,281 patients with 2,885,450 dialysis treatments during Fiscal 2025. The company has strategic partnerships with several established hospital chains to operate in-house dialysis centers.
Timeline information will be updated when available.
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 26.82x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 24.77x | Oversubscribed |
| RII (Retail Individual Investors) | 2.36x | Oversubscribed |
| Total Subscription | 14.08x | Oversubscribed |
Last updated: Dec 12, 2025, 06:21 PM
Potential challenges and risk factors
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹460.00 | ₹460.00 |
| High | ₹498.70 | ₹499.00 |
| Last Trade | ₹471.60 | ₹471.25 |
| Low | ₹463.50 | ₹463.80 |
| Open | ₹491.70 | ₹490.00 |